(HealthDay)—The use of bone morphogenetic protein (BMP) is not associated with operative nonunion rates after spinal fusion, according to a study published in the Oct. 15 issue of Spine.
Oct 24, 2014
0
0
(HealthDay)—Patients undergoing lumbar spine surgery at teaching hospitals incur longer hospitalizations and have more postoperative complications compared to those treated at nonteaching hospitals, according to a study ...
Mar 12, 2014
0
0
(Medical Xpress)—A spinal interbody fusion implant with a roughened titanium alloy surface provides an enhanced environment for bone formation, implant stability and fusion compared to one with a smooth titanium alloy surface, ...
Sep 24, 2013
0
0
(HealthDay)—For patients undergoing spine fusion for adult spinal deformity, unplanned hospital readmissions are relatively common and are often related to surgical site infections, according to a study published in the ...
Sep 11, 2013
0
0
(HealthDay)—Postoperative posttraumatic stress disorder (PTSD) symptoms are strongly correlated with reduced clinical benefit from elective lumbar spinal fusion, according to a study published in the Aug. 1 issue of Spine.
Aug 14, 2013
0
0
(HealthDay)—The most frequent procedure performed during hospitalization in 2010 was blood transfusion, which was common among all age groups except for infants, according to the Agency for Healthcare Research and Quality ...
Jul 11, 2013
0
0
Interspinous spacer implantation—a less-invasive alternative surgical option for spinal stenosis—has a lower complication rate than spinal fusion, reports a study in the May 1 issue of Spine.
May 7, 2013
0
0
(HealthDay)—A substantially high number of patients undergoing spinal fusion have a vitamin D deficiency or inadequacy, according to a study published in the March 15 issue of Spine.
Mar 28, 2013
0
0
(HealthDay)—The da Vinci Robotic Surgical System can be used for anterior lumbar interbody fusion, according to a case report published in the Feb. 15 issue of Spine.
Mar 12, 2013
0
0
(HealthDay)—The effect of osteoporosis therapies (bisphosphonate drugs and intermittent parathyroid hormone [PTH]) on spinal fusion is unclear, according to a review published in the February issue of The Spine Journal.
Mar 1, 2013
0
0
